Pain and Smoking: A Program to Help Veterans Quit Smoking with Chronic Pain
Official title: Enhancing an Intervention for Smokers With Chronic Pain Using IVR: A Randomized Clinical Trial of Smoking Cessation Counseling for Veterans
Run by VA Office of Research and Development · NCT06442514 · Data updated 2026-11-12
This study tests whether the PASS2 program, which adds nightly surveys to a pain-and-smoking cessation intervention, helps Veterans with chronic pain quit smoking better than usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (West Haven, Connecticut) |
| Status | Recruiting |
| Started | September 21, 2026 |
| Main results expected | May 31, 2028 |
| Study ends | May 31, 2028 |
| Registry record updated | September 29, 2026 |
| Trial ID | NCT06442514 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Enrolled Veterans at VACHS who currently smoke, are willing to quit, and have significant chronic pain (BPI pain intensity ≥4 for ≥90 days).
✕Probably not a fit
Individuals with severe depressive symptoms, cognitive impairment, or other exclusion criteria may not experience benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
PASS2 expands on a prior intervention by adding nightly surveys to support smoking cessation in Veterans who have chronic pain. The trial compares PASS2 to standard care (referral to a VA smoking cessation clinic) with pharmacotherapy tele-consult, tracking abstinence at 4 and 10 months. It also compares PASS2 to standard care on pain interference and aims to identify which parts of the intervention are most important for implementation. Eligible participants are enrolled Veterans with current tobacco use, significant chronic pain, and no exclusion criteria such as dementia, active psychosis, or lack of telephone access. The study is conducted at the VA Connecticut Healthcare System West Haven Campus.
Why it matters
Potential benefit: If successful, PASS2 could improve smoking abstinence rates and reduce pain-related interference in daily life for Veterans with chronic pain.
How similar studies have gone: Prior work with the PASS intervention showed promise, and PASS2 builds on that approach by adding nightly surveys to optimize outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * being an enrolled Veteran at VACHS * current tobacco use * willingness to make a quit attempt * significant chronic pain defined as \>/=4 on the pain intensity portion of the Brief Pain Inventory (BPI) for more than 90 days Exclusion Criteria: * active diagnosis of dementia or psychosis in medical record * severely impaired hearing or speech * lack of telephone access * enrollment in concurrent research study that might affect main outcomes of this study * terminal illness * non-English speaking * pregnancy * provider advising against exercise * planned surgeries * clinically significant depressive symptoms (\>10 PHQ-9)
Where it's running
-
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut, United States Recruiting
Study contacts
- Principal investigator: Lori Anne Bastian, MD MPH — VA Connecticut Healthcare System West Haven Campus, West Haven, CT
- Study coordinator: Lori A Bastian, MD MPH
- Email: Lori.Bastian@va.gov
- Phone: (203) 932-5711
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Personalized treatment to help people with cancer quit smoking and live longer
We will test whether personalized tobacco treatment using clinical, genetic, and biomarker information helps cancer patients who smoke quit and use cessation medications more than usual care.
-
Actívatexto: Helping Latinos quit smoking and become more active
This trial tests whether Actívatexto, a text-message program combined with wearables and nicotine replacement, helps Latino adults who smoke quit and increase their physical activity.
-
Quitting Matters: a smoking quit program for people living with HIV
This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.
-
Technology-based motivational interviewing to help adults quit smoking
This project will try a chatbot-based motivational interviewing coach to help adult primary care patients who smoke become ready to quit and create a personalized quit plan.
-
Using an air quality monitor to encourage smoke-free homes for cancer patients
This study is testing if using an air quality monitor can help cancer patients who smoke create smoke-free homes and quit smoking.
-
Proactive tobacco treatment for household smokers through pediatric care
This study is testing a new way to help household smokers quit tobacco by using support from pediatric care to see if it can improve their chances of success.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.